|
1 Company |
|
1 Product |
|
1 Product |
|
2 Mechanisms of Action |
|
0 Trials |
|
16 News |
|
- | Trial completion: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 1, 2018
P2, N=100, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Completed
- | Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Apr 13, 2017
P2, N=100, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Completed Trial primary completion date: Aug 2016 --> Aug 2018
- | Trial completion, Trial primary completion date, Stroma: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors (clinicaltrials.gov) - Jul 14, 2016
P=N/A, N=50, Completed, Sponsor: Children's Oncology Group
Trial primary completion date: Aug 2016 --> Aug 2018 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Jul 2016
- Trial completion, Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Oct 9, 2015
P=N/A, N=39, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Jul 2016 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Aug 12, 2015
P1, N=12, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012 Active, not recruiting --> Completed
- Enrollment open, Enrollment change, Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Aug 11, 2015
P2, N=100, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016
- Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016 Trial primary completion date: Sep 2014 --> Jul 2015
- Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: Sep 2014 --> Jul 2015 Trial primary completion date: Sep 2013 --> Sep 2015
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment change, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jun 6, 2015
P1, N=12, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Trial primary completion date: Sep 2013 --> Sep 2015 N=20 --> 12
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment closed, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - May 27, 2014
P1, N=20, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
N=20 --> 12 Recruiting --> Active, not recruiting
- Enrollment closed, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jul 25, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=48, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- | New P2 trial: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
New P1 trial, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jul 26, 2012
P1, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
- Stroma: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors (clinicaltrials.gov) - Apr 4, 2012
P=N/A, N=50, Active, not recruiting, Sponsor: Children's Oncology Group